( January 28, 2026, 2:34 PM EST) -- LAFAYETTE, La. — The government on Jan. 27 asked a Louisiana federal court to stay all proceedings in a case brought by the state that challenges the validity of the U.S. Food and Drug Administration’s 2023 decision to remove the in-person dispensing requirement for mifepristone, one of two drugs used to induce early termination of pregnancy, while it conducts a review of the agency’s previous rulings....